Sofinnova Investments Announces the Appointment of Dr. Merdad Parsey as Executive Partner
Sofinnova Investments, a biopharmaceutical investment firm, announced today the addition of Merdad Parsey, M.D., Ph.D., to the investment team as an Executive Partner.
Sofinnova Investments Announces the Addition of Dr. Maha Radhakrishnan as Executive Partner
Sofinnova Investments, a biopharmaceutical investment firm, announced today the addition of Maha Radhakrishnan, M.D. to the investment team as an Executive Partner.
Sofinnova Investments Appoints Troy Ignelzi as Executive Advisor
Sofinnova Investments, a healthcare investment firm, announced today the appointment of Troy Ignelzi to the investment team as an Executive Advisor. In this role, he will be advising Sofinnova’s portfolio companies on corporate and financial strategy.
Sofinnova Investments Appoints Dr. Jakob Dupont as Executive Partner
Sofinnova Investments, a healthcare investment firm, announced today the appointment of Jakob Dupont, M.D., to the investment team as an Executive Partner.
Sofinnova Investments Announces the Addition of Dr. Chris Carpenter as Executive Partner
Sofinnova Investments, a biopharmaceutical investment firm, announced today the addition of Chris Carpenter, M.D., Ph.D., to the investment team as an Executive Partner.
